Covered recipient · General Payments record
SAMANTHA KAYE RICHARD
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$1,225.73
- Reported across 77 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $325.72 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $74.57 | 4 |
| ABBVIE INC. | $72.24 | 4 |
| GlaxoSmithKline, LLC. | $48.53 | 2 |
| Lilly USA, LLC | $37.48 | 2 |
| PFIZER INC. | $32.94 | 2 |
| Otsuka America Pharmaceutical, Inc. | $17.54 | 1 |
| Sumitomo Pharma America, Inc. | $15.23 | 1 |
| Acerta Pharma LLC | $13.87 | 1 |
| Axsome Therapeutics, Inc. | $13.32 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.34 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108082422 | CMS |
| ABBVIE INC. | $20.28 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108082424 | CMS |
| ABBVIE INC. | $19.79 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108082426 | CMS |
| ABBVIE INC. | $17.83 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108082428 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.87 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104556246 | CMS |
| Axsome Therapeutics, Inc. | $13.32 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148406230 | CMS |
| GlaxoSmithKline, LLC. | $20.59 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115912318 | CMS |
| GlaxoSmithKline, LLC. | $27.94 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115732989 | CMS |
| Lilly USA, LLC | $16.33 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135957549 | CMS |
| Lilly USA, LLC | $21.15 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135927834 | CMS |
| Novo Nordisk Inc | $15.78 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100506185 | CMS |
| Novo Nordisk Inc | $19.90 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100461716 | CMS |
| Novo Nordisk Inc | $18.89 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100634627 | CMS |
| Novo Nordisk Inc | $20.00 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100496853 | CMS |
| Otsuka America Pharmaceutical, Inc. | $17.54 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119171340 | CMS |
| PFIZER INC. | $15.63 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131317378 | CMS |
| PFIZER INC. | $17.31 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131775539 | CMS |
| Sumitomo Pharma America, Inc. | $15.23 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148990518 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.